Detalhe da pesquisa
1.
Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial.
Lancet Oncol
; 24(3): 286-296, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37052965
2.
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial.
Gynecol Oncol
; 172: 72-77, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36965291
3.
Clinical characteristics and molecular aspects of low-grade serous ovarian and peritoneal cancer: a multicenter, observational, retrospective analysis of MITO Group (MITO 22).
Br J Cancer
; 127(8): 1479-1486, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869143
4.
Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.
Int J Gynecol Cancer
; 32(6): 799-803, 2022 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35318277
5.
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
BMC Cancer
; 21(1): 549, 2021 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985435
6.
A qualitative analysis and development of a conceptual model assessing financial toxicity in cancer patients accessing the universal healthcare system.
Support Care Cancer
; 29(6): 3219-3233, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094357
7.
Arthralgia in patients with ovarian cancer treated with bevacizumab and chemotherapy.
Int J Gynecol Cancer
; 31(1): 110-113, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32796087
8.
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
Int J Gynecol Cancer
; 31(7): 1031-1036, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33990353
9.
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial.
Int J Gynecol Cancer
; 31(10): 1348-1355, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462317
10.
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study.
Int J Gynecol Cancer
; 31(6): 875-882, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33931498
11.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
J Transl Med
; 18(1): 405, 2020 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-33087150
12.
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Gynecol Oncol
; 156(1): 38-44, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31699415
13.
Evaluation of Allergic Diseases, Symptom Control, and Relation to Infections in a Group of Italian Elite Mountain Bikers.
Clin J Sport Med
; 30(5): 465-469, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365469
14.
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials.
Gynecol Oncol
; 154(1): 83-88, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31029508
15.
Emesis and nausea related to single agent trabectedin in ovarian cancer patients: a sub-study of the MITO15 project.
Support Care Cancer
; 25(6): 1743-1748, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28101677
16.
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
J Transl Med
; 19(1): 442, 2021 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674735
17.
Long-Term Toxicity and Quality of Life in Patients Treated for Locally Advanced Cervical Cancer.
Oncology
; 90(1): 29-35, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26473609
18.
Maternal non-Mendelian inheritance of a reduced lifespan? A hypothesis.
J Assist Reprod Genet
; 31(6): 637-43, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687877
19.
Corrigendum to "Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study" [The Lancet Regional Health - Europe 41 (2024) 100912].
Lancet Reg Health Eur
; 42: 100940, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38813536
20.
Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.
Lancet Reg Health Eur
; 41: 100912, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38665620